FLT3 Wild Type (WT)
Showing 1 - 25 of >10,000
AML, Adult Trial in Berne (HDM201, Midostaurin)
Terminated
- AML, Adult
-
Berne, SwitzerlandDepartement of Medical Oncology, University Hospital Berne
Oct 3, 2022
Stage IV Melanoma, Stage III Melanoma Trial in Jette (Trametinib, Dabrafenib)
Recruiting
- Stage IV Melanoma
- Stage III Melanoma
-
Jette, Brussels, BelgiumUniversitair Ziekenhuis Brussel
Sep 29, 2021
HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)
Recruiting
- HR+/HER2- Advanced Breast Cancer
- Targeted Therapy
- Everolimus
- +3 more
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Aug 1, 2023
Metastatic Colorectal Cancer. Real-World Data Analysis.
Completed
- Metastatic Colorectal Cancer
-
Istanbul, TurkeyIstanbul Medeniyet University Hospital
Oct 25, 2021
Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,
Not yet recruiting
- Recurrent Glioblastoma, IDH-Wildtype
- +2 more
- Biospecimen Collection
- +2 more
- (no location specified)
May 13, 2023
Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)
Recruiting
- Acute Myeloid Leukemia
- Biospecimen Collection
- +5 more
-
Buffalo, New York
- +1 more
Jan 27, 2023
Endometrial Cancer Trial in Israel, United States (Selinexor, Matching Placebo for selinexor)
Recruiting
- Endometrial Cancer
- Selinexor
- Matching Placebo for selinexor
-
Miami Beach, Florida
- +6 more
Jan 31, 2023
Ataxia, Spinocerebellar, Insulin-Like Growth Factor I, Medicine, Chinese Traditional Trial in Changhua (Chinese medicine WT)
Recruiting
- Ataxia, Spinocerebellar
- +2 more
- Chinese medicine WT
-
Changhua, TaiwanChanghua Christian Hospital
Oct 22, 2021
Multiple Myeloma Trial in New York (CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs), Standard of care)
Completed
- Multiple Myeloma
- CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs)
- Standard of care
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 22, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (drug, other, biological)
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Bortezomib
- +4 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 5, 2022
Colo-rectal Cancer Trial in Beijing (Experimental: mXELOX plus cetuximab, Active Comparator: FOLFOX plus cetuximab)
Recruiting
- Colo-rectal Cancer
- Experimental: mXELOX plus cetuximab
- Active Comparator: FOLFOX plus cetuximab
-
Beijing, ChinaCancer Hospital & Institute, Chinese Academy of Medical Sciences
Sep 29, 2021
Metastatic Colorectal Cancer Trial in Worldwide (Futuximab/modotuximab, Trifluridine/Tipiracil)
Recruiting
- Metastatic Colorectal Cancer
- Futuximab/modotuximab
- Trifluridine/Tipiracil
-
Ann Arbor, Michigan
- +10 more
Dec 2, 2022
Acute Myeloid Leukemia Trial in Spain (Quizartinib, Placebo oral tablet, Cytarabine)
Active, not recruiting
- Acute Myeloid Leukemia
- Quizartinib
- +3 more
-
Santiago De Compostela, A Coruña, Spain
- +44 more
Jan 20, 2022
Colorectal Cancer, Metastatic Colorectal Cancer, RAS Mutation Trial in Italy (Bevacizumab, Cetuximab, 5-FU)
Recruiting
- Colorectal Cancer
- +2 more
- Bevacizumab
- +4 more
-
Coppito, L'Aquila, Italy
- +3 more
Sep 10, 2021
Metastatic Colorectal Cancer Trial in United States (Trastuzumab, Cetuximab, Neratinib)
Active, not recruiting
- Metastatic Colorectal Cancer
- Trastuzumab
- +3 more
-
Anaheim, California
- +47 more
Mar 28, 2022
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Germany, United States (Emavusertib, Azacitidine, Venetoclax)
Active, not recruiting
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Emavusertib
- +2 more
-
Tampa, Florida
- +8 more
Apr 5, 2022
NSCLC (NSCLC) Trial in China (Capmatinib)
Recruiting
- Non-Small Cell Lung Cancer (NSCLC)
-
Xiamen, Fujian, China
- +18 more
Jan 27, 2023
Advanced Solid and Hematological TP53wt Tumors Trial in Worldwide (HDM201, ancillary treatment)
Completed
- Advanced Solid and Hematological TP53wt Tumors
- HDM201
- ancillary treatment
-
Boston, Massachusetts
- +14 more
May 20, 2021
NSCLC Trial in Worldwide (INC280 (capmatinib))
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- INC280 (capmatinib)
-
Long Beach, California
- +95 more
Dec 29, 2022
Polyneuropathy, Amyloidosis Trial in Jette (ECG + echocardiography, Answering questionnaires)
Recruiting
- Polyneuropathy
- Amyloidosis
- ECG + echocardiography
- Answering questionnaires
-
Jette, Belgium Capital City, BelgiumUZ Brussel
Jul 14, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +4 more
- Pelareorep
- +3 more
-
New Brunswick, New Jersey
- +1 more
Sep 26, 2022